迈普医学:可吸收止血流体明胶作为第三类医疗器械进入临床试验

智通财经
Sep 08
【迈普医学:可吸收止血流体明胶作为第三类医疗器械进入临床试验】迈普医学公告,公司研发项目“可吸收止血流体明胶”近期正式进入临床试验阶段,注册分类为第三类医疗器械,用于外科手术辅助止血;临床试验完成后,公司将开展注册申报及后续产业化、上市销售工作。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10